CopyTele, Inc. — Form 10-K Summary
Entity note: The supplied filing is for CopyTele, Inc., not Anixa Biosciences, Inc. It reports the fiscal year ended October 31, 2011; the filing also provides unaudited fourth-quarter results.
Business context and reporting period
CopyTele developed display technologies, including E-Paper and low-voltage Nano Displays, and encryption products and services. Its display technologies were largely still under development; reported display revenue primarily came from license fees. The company entered worldwide technology license agreements with AU Optronics (AUO) in May 2011 and continued its earlier arrangement with Videocon.
Financial performance and liquidity
| Metric | FY 2011 | FY 2010 |
|---|---|---|
| Net revenue | $1.003 million | $0.731 million |
| Operating loss | $5.028 million | $5.248 million |
| Net loss | $7.378 million | $5.175 million |
| Net loss per share, basic and diluted | $0.04 | $0.03 |
| Net cash used in operating activities | $0.716 million | $2.406 million |
- Revenue increased by about $272,000, mainly because AUO license-fee revenue was approximately $873,000; encryption product revenue was approximately $131,000, essentially unchanged.
- The larger net loss included a $1.786 million impairment charge on available-for-sale securities and a $600,000 income-tax provision related to withholding tax on AUO’s license payment. Research and development expense was $3.125 million, versus $3.007 million; selling, general and administrative expense was $2.873 million, versus $2.889 million.
- Fourth-quarter FY 2011 revenue was $448,960 and net loss was $2.791 million, compared with fourth-quarter FY 2010 revenue of $311,250 and net loss of $1.127 million.
- At year-end, cash and cash equivalents were $774,040 and short-term U.S. government securities and certificates of deposit were $2.249 million, totaling approximately $3.023 million. Working capital was approximately $1.015 million; total assets were $8.646 million and shareholders’ equity was $1.058 million.
- Cash from financing was $2.534 million, including $1.250 million from a private placement and $1.284 million from option exercises. The company issued 7 million shares and warrants for another 7 million shares in the private placement.
- A $5 million related-party loan payable is due in December 2014. A matching $5 million related-party loan receivable is presented as a reduction of equity; the associated securities are pledged and subject to a seven-year lock-up.
Material changes, outlook, and risks
- AUO agreed to pay up to $10 million in license fees: $3 million was paid in June 2011, of which $2.4 million was received net of 20% withholding tax; the remaining $7 million depends on conditions that may not be completed. Approximately $2.127 million of the initial fee remained deferred as revenue at year-end. No AUO royalties had been recognized.
- Videocon’s license agreement provides for $11 million in fees, but payments were deferred as the parties worked on technology improvements. CopyTele had received $3.2 million cumulatively by October 31, 2011, received none from Videocon in FY 2011, and could not estimate future payment dates. No Videocon royalties had been earned.
- Display revenue was highly concentrated: AUO represented approximately 87% of total FY 2011 revenue, compared with Videocon at approximately 82% in FY 2010. The company also reported a $5.382 million Videocon investment, down from $8.525 million, and recorded an impairment; further declines and foreign-exchange movements could affect its value.
- Management expected available resources and anticipated cash flows to fund operations for at least 12 months, but warned that revenue, license payments, and financing were uncertain. It had no additional financing arrangements and said a funding shortfall could require curtailing or ceasing operations. Further equity or convertible-debt issuance could dilute shareholders.
- Other risks include continued losses and operating cash outflows, dependence on a small number of customers and foreign counterparties, uncommercialized display technologies, competition and obsolescence, and reliance on key personnel. A $1.786 million impairment was recorded for the Videocon and DISC investments; DISC was written down to zero.
- No material pending legal proceedings were reported. Management concluded disclosure controls and internal control over financial reporting were effective at year-end; the internal-control assessment was not audited by the independent auditor. The company reported no long-term obligations in selected financial data, while separately disclosing the $5 million loan payable due in 2014.
Important facts for investors to verify
- Confirm the issuer: this filing identifies CopyTele, Inc., not Anixa Biosciences, Inc.
- Review AUO’s remaining-fee conditions, timing, withholding-tax treatment, and any subsequent royalties or production progress.
- Check the status and revised payment terms of Videocon’s deferred license fees and whether any royalties or payments were received after year-end.
- Assess liquidity against recurring operating losses, customer concentration, the related-party loan and pledged securities, and potential dilution from outstanding options and warrants.
- Review the valuation and impairment assumptions for the Videocon investment and the complete audited financial statements and notes.